These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25333998)
41. [Promoting effect of all-trans retinoic acid on the chemosensitivity of esophageal cancer EC9706 cells]. Lu TY; Li X; Li WB; Wang LX; Gao DL; Wang RL; Lu SX; Fan QX Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):663-6. PubMed ID: 21122379 [TBL] [Abstract][Full Text] [Related]
42. Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells. Yim EK; Lee SB; Lee KH; Kim CJ; Park JS Int J Gynecol Cancer; 2006; 16(3):1321-9. PubMed ID: 16803524 [TBL] [Abstract][Full Text] [Related]
43. [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV]. Bando K; Onda M; Miyashita M; Takahashi Y; Takita M; Matsutani T; Okawa K; Sasajima K; Ujihara Y; Takubo K; Yamashita K Gan To Kagaku Ryoho; 1998 May; 25(6):915-8. PubMed ID: 9617331 [TBL] [Abstract][Full Text] [Related]
44. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma]. Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688 [TBL] [Abstract][Full Text] [Related]
45. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma. Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177 [TBL] [Abstract][Full Text] [Related]
46. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
47. In Vitro Assessment of the Cytotoxic Effect of 5-Fluorouracil, Thymoquinone and their Combination on Tongue Squamous Cell Carcinoma Cell Line. Eloraby DAI; El-Gayar SF; El-Bolok AH; Ammar SG; ElShafei MM Asian Pac J Cancer Prev; 2024 Jun; 25(6):2169-2176. PubMed ID: 38918680 [TBL] [Abstract][Full Text] [Related]
48. Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production. Sung MW; Lee DY; Park SW; Oh SM; Choi JJ; Shin ES; Kwon SK; Ahn SH; Kim YH Laryngoscope; 2017 Apr; 127(4):E117-E123. PubMed ID: 27666139 [TBL] [Abstract][Full Text] [Related]
49. Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation. Zhang C; Luo CL; Shang GS; Jiang DX; Song Q Med Sci Monit; 2021 Dec; 27():e931630. PubMed ID: 34916479 [TBL] [Abstract][Full Text] [Related]
50. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma. Harada K; Ferdous T; Harada T; Ueyama Y Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058 [TBL] [Abstract][Full Text] [Related]
51. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway]. Tian F; Song M; Xu PR; Liu HT; Xue LX Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726 [TBL] [Abstract][Full Text] [Related]
52. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Zou K; Ju JH; Xie H Acta Pharmacol Sin; 2007 May; 28(5):721-30. PubMed ID: 17439729 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504 [TBL] [Abstract][Full Text] [Related]
54. Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB. Li J; Minnich DJ; Camp ER; Brank A; Mackay SL; Hochwald SN J Surg Res; 2006 May; 132(1):112-20. PubMed ID: 16337965 [TBL] [Abstract][Full Text] [Related]
55. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma. Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207 [TBL] [Abstract][Full Text] [Related]
56. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
57. BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation. Wang XT; Bao CH; Jia YB; Wang N; Ma W; Liu F; Wang C; Wang JB; Song QX; Cheng YF Biochem Biophys Res Commun; 2014 Oct; 452(4):945-50. PubMed ID: 25223594 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma. Miyawaki Y; Nakajima Y; Kawada K; Okada T; Tokairin Y; Kawano T Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27001629 [TBL] [Abstract][Full Text] [Related]
59. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. O'Donovan TR; O'Sullivan GC; McKenna SL Autophagy; 2011 May; 7(5):509-24. PubMed ID: 21325880 [TBL] [Abstract][Full Text] [Related]
60. Suppression of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by STAT3 Silencing. Xu DD; Chen SH; Zhou PJ; Wang Y; Zhao ZD; Wang X; Huang HQ; Xue X; Liu QY; Wang YF; Zhang R Front Pharmacol; 2020; 11():532395. PubMed ID: 33390934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]